SCHEMBL5696642

SCHEMBL5696642

COCC(=O)Oc1ccc(OC(=O)COC)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.59
LMNA P02545 3/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
HTT P42858 1/20 0.59
HSD17B10 Q99714 1/20 0.59
GAA P10253 3/20 0.56
TDP1 Q9NUW8 2/20 0.49
ESR1 P03372 2/20 0.48
HIF1A Q16665 2/20 0.48
RECQL P46063 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PDGFRB P09619 1/20 0.48
PDGFRA P16234 1/20 0.48
CA2 P00918 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.44
NPC1 O15118 1/20 0.44
ELANE P08246 1/20 0.44
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18087017 0.94 LMNA (0.53) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL28905911 0.90 LMNA (0.50) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL248163 0.89 GAA (0.50) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL14218905 0.87 SMN1; SMN2 (0.54) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL6610147 0.86 KMT2A (0.46) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL19294787 0.85 KMT2A (0.46) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL10311842 0.84 BCL9 (0.67) KMT2ALMNAALDH1A1MAPTHSD17B10
SCHEMBL28627409 0.84 LMNA (0.52) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL10824946 0.82 ALDH1A1 (0.56) KMT2ALMNAALDH1A1MAPTHTT
SCHEMBL13298324 0.82 TDP1 (0.48) KMT2ALMNAALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112050-A1 HMGCoA reductase inhibitor combinations and uses thereof PSIVIDA INC. (US) 2007-05-17 US disclosed
US-20070112050-A1 HMGCoA reductase inhibitor combinations and uses thereof PSIVIDA INC. (US) 2007-05-17 US disclosed
EP-1118644-B1 Hot melt printing ink SIEGWERK DRUCKFARBEN AG (DE) 2006-06-14 EP disclosed
EP-1118644-A2 Hot melt printing ink Siegwerk Druckfarben GmbH & Co. KG (DE) 2001-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112050-A1 HMGCoA reductase inhibitor combinations and uses thereof HMGCR, HMGB2, HMGB3 KMT2A 973/4885LMNA 394/4885ALDH1A1 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.